The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Open accessAbstract
BACE1 is required for the release of beta-amyloid (Abeta) in vivo, and inhibition of BACE1 activity is targeted for reducing Abeta generation in Alzheimer's patients. To further our understanding of the safe use of BACE1 inhibitors in human patients, we aimed to study the physiological functions of BACE1 by characterizing BACE1-null mice. Here, we report the finding of spontaneous behavioral seizures in BACE1-null mice. Electroencephalographic recordings revealed abnormal spike-wave discharges in BACE1-null mice, and kainic acid-induced seizures also occurred more frequently in BACE1-null mice compared with their wild-type littermates. Biochemical and morphological studies showed that axonal and surface levels of Na(v)1.2 were significantly elevated in BACE1-null mice, consistent with the increased fast sodium channel current recorded from BACE1-null hippocampal neurons. Patch-clamp recording also showed altered intrinsic firing properties of isolated BACE1-null hippocampal neurons. Furthermore, population spikes were significantly increased in BACE1-null brain slices, indicating hyperexcitability of BACE1-null neurons. Together, our results suggest that increased sodium channel activity contributes to the epileptic behaviors observed in BACE1-null mice. The knowledge from this study is crucial for the development of BACE1 inhibitors for Alzheimer's therapy and to the applicative study of epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, BACE1 KO mice exhibit a variety of neurological defects [641–643]”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [643]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,141
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“BACE1 was identified as the Alzheimer’s -secretase, which cleaves amyloid precursor protein (APP) at the N-terminal end of the -amyloid peptide (A ) (Hussain et al., 1999; Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999; Lin et al., 2000).”
BackgroundFrom Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,124
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Self-citationYu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D. B., Wen, H., Borchelt, D., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,087
Self-citationIdentification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030
Self-citationLuo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., & Tang, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1456 · Cited by 769
Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684
Bace1 modulates myelination in the central and peripheral nervous system
Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608
Self-citationLaird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H.-C., Xu, G., Koliatsos, V. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-05.2005 · Cited by 521
Self-citationCompact myelin dictates the differential targeting of two sodium channel isoforms in the same axon.
Boiko, T., Rasband, M., Levinson, S., Caldwell, J., Mandel, G., Trimmer, J. S., & Matthews, G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00265-3 · Cited by 434
Sodium-channel defects in benign familial neonatal-infantile seizures
Heron, S. E., Crossland, K. M., Andermann, E., Phillips, H. A., Hall, A. J., Bleasel, A., Shevell, M. I., Mercho, S., Seni, M., Guiot, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09968-3 · Cited by 378
Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice
Dominguez, D. I., Tournoy, J., Hartmann, D., Huth, T., Cryns, K., Deforce, S., Serneels, L., Espuny-Camacho, I., Marjaux, E., Craessaerts, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505249200 · Cited by 359
Kaplan, M. R., Cho, M.-H., Ullian, E. M., Isom, L. L., Levinson, S. R., & Barres, B. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00266-5 · Cited by 304
BACE1 regulates voltage-gated sodium channels and neuronal activity
Kim, D. Y., Carey, B. W., Wang, H., Ingano, L. A. M., Binshtok, A. M., Wertz, M. H., Pettingell, W. H., He, P., Lee, V. M. ‐., Woolf, C. J., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1602 · Cited by 301
Wong, H. K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, M., Strooper, B. D., Säftig, P., & Nukina, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414648200 · Cited by 290
Savonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K.-A., Price, D. L., & Wong, P. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710373105 · Cited by 290
Self-citationBenign familial neonatal‐infantile seizures: Characterization of a new sodium channelopathy
Berkovic, S. F., Heron, S. E., Giordano, L., Marini, C., Guerrini, R., Kaplan, R. E., Gambardella, A., Steinlein, O. K., Grinton, B. E., Dean, J. T., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20029 · Cited by 285
The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate
von Arnim, C. A. F., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 258
Chen, C., Westenbroek, R. E., Xu, X., Edwards, C. A., Sorenson, D. R., Chen, Y., McEwen, D. P., O’Malley, H. A., Bharucha, V. A., Meadows, L. S., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4139-03.2004 · Cited by 258
Reticulon family members modulate BACE1 activity and amyloid-β peptide generation
He, W., Lu, Y., Qahwash, I. M., Hu, X., Chang, A., & Yan, R. (2004) · Nature Medicine · doi:10.1038/nm1088 · Cited by 257
Self-citationPersistent Sodium Current and Its Role in Epilepsy
Stafstrom, C. E. (2007) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2007.00156.x · Cited by 249
Kearney, J. A., Plummer, N. W., Smith, M. R., Kapur, J., Cummins, T., Waxman, S. G., Goldin, A. L., & Meisler, M. H. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00479-6 · Cited by 242
Inherited Neuronal Ion Channelopathies: New Windows on Complex Neurological Diseases
Catterall, W. A., Dib-Hajj, S., Meisler, M. H., & Pietrobon, D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3901-08.2008 · Cited by 237
Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 232
Lichtenthaler, S. F., Dominguez, D.-I., Westmeyer, G. G., Reiss, K., Haass, C., Saftig, P., De Strooper, B., & Seed, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303861200 · Cited by 206
Chen, C.-L., Bharucha, V., Chen, Y., Westenbroek, R., Brown, A. M., Malhotra, J., Jones, D. M., Avery, C., Gillespie, P., Kazen-Gillespie, K., et al. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.212638099 · Cited by 203
Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1
Li, Q., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310001200 · Cited by 180
Yan, R., Han, P., Miao, H., Greengard, P., & Xu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104350200 · Cited by 179
Self-citationActivity-Evoked Capacitative Ca2+Entry: Implications in Synaptic Plasticity
Baba, A., Yasui, T., Fujisawa, S., Yamada, R. X., Yamada, M. K., Nishiyama, N., Matsuki, N., & Ikegaya, Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07737.2003 · Cited by 171
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
Hu, X., He, W., Diaconu, C., Tang, X., Kidd, G. J., Macklin, W. B., Trapp, B. D., & Yan, R. (2008) · The FASEB Journal · doi:10.1096/fj.08-106666 · Cited by 155
Self-citationKim, D. Y., Ingano, L. A. M., Carey, B. W., Pettingell, W. H., & Kovacs, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412938200 · Cited by 151
Molecular Mechanisms of Gating and Drug Block of Sodium Channels
Carterall, W. A. (2001) · Novartis Foundation symposium · doi:10.1002/0470846682.ch14 · Cited by 145
Elevated expression of type II Na+ channels in hypomyelinated axons of shiverer mouse brain
Westenbroek, R. E., Noebels, J. L., & Catterall, W. A. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-06-02259.1992 · Cited by 139
Scalmani, P., Rusconi, R., Armatura, E., Zara, F., AVANZINI, G., Franceschetti, S., & Mantegazza, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2476-06.2006 · Cited by 122
Wang, H., Song, L., Laird, F. M., Wong, P. C., & Lee, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2440-08.2008 · Cited by 116
Self-citationWu, G., Lu, Z., Wang, J., Wang, Y., Xie, X., MEYENHOFER, M. F., & Ledeen, R. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3635-05.2005 · Cited by 114
BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer’s disease
Kobayashi, D., Zeller, M., Cole, T., Buttini, M., McConlogue, L., Sinha, S., Freedman, S., Morris, R. G. M., & Chen, K. S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.002 · Cited by 111
BACE (β-secretase) modulates the processing of APLP2 in vivo
Pastorino, L., Ikin, A. F., Lamprianou, S., Vacaresse, N., Revelli, J., Platt, K. A., Paganetti, P., Mathews, P. M., Harroch, S., & Buxbaum, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.013 · Cited by 106
Sodium channel density in hypomyelinated brain increased by myelin basic protein gene deletion
Noebels, J. L., Marcom, P. K., & Tehrani, M. H. J. (1991) · Nature · doi:10.1038/352431a0 · Cited by 86
A Novel SCN2A Mutation in Family with Benign Familial Infantile Seizures
Striano, P., Bordo, L., Lispi, M. L., Specchio, N., Minetti, C., Vigevano, F., & Zara, F. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00392.x · Cited by 83
Luhmann, H. J., Dzhala, V. I., & Ben‐Ari, Y. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00156.x · Cited by 68
Modulators of neuronal cell death in epilepsy
Henshall, D. C., & Murphy, B. M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.07.005 · Cited by 64
Qahwash, I. M., Weiland, K. L., Lu, Y., Sarver, R. W., Kletzien, R. F., & Yan, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213298200 · Cited by 45
Self-citationNon-proteolytic effect of β-site APP-cleaving enzyme 1 (BACE1) on sodium channel function
Huth, T., Schmidt-Neuenfeldt, K., Rittger, A., Säftig, P., Reiß, K., & Alzheimer, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.015 · Cited by 41
β Subunits: Players in Neuronal Hyperexcitability?
Isom, L. L. (2001) · Novartis Foundation symposium · doi:10.1002/0470846682.ch9 · Cited by 35
Yu, E. J., Ko, S.-H., Lenkowski, P. W., Pance, A., Patel, M. K., & Jackson, A. P. (2005) · Biochemical Journal · doi:10.1042/bj20050518 · Cited by 31
Neuregulins and Neuronal Plasticity: Possible Relevance in Schizophrenia
Buonanno, A., Kwon, O., Yan, L., González, C., Longart, M., Hoffman, D. A., & Vullhorst, D. (2008) · Novartis Foundation symposium · doi:10.1002/9780470751251.ch13 · Cited by 19
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Yan, R., & Vassar, R. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70276-x · Cited by 645
Self-citationKent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Kennedy, M. E., Stamford, A. W., Chen, X., Cox, K., Cumming, J. N., Dockendorf, M. F., Egan, M. F., Ereshefsky, L., Hodgson, R. A., Hyde, L. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9704 · Cited by 441
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Vassar, R. J. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0089-7 · Cited by 421
Metadata
- Authors
- Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R.
- Affiliations
- Cleveland Clinic (US)
- Augusta University (US)
- Johns Hopkins University (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-06-30
- Volume
- 30
- Issue
- 26
- Pages
- 8819-8829
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2902368
- OpenAlex
- W2017917068
- Cited by
- 162
- References
- 55
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 13 · 2015: 11 · 2014: 19 · 2013: 16 · 2012: 16
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association (AG025493)
- American Health Assistance Foundation (AG025493)
- Wilson Foundation
- Ralph C. Wilson Foundation (AG025493)
- National Institutes of Health (AG025493)
- National Institute on Aging (R01AG025493, RF1AG025493, AG025493)
- National Heart, Lung, and Blood Institute (R01HL081622, HL081622)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- BACE1, amyloid-beta, Alzheimer's disease, BACE1 inhibitors, spontaneous seizures, spike-wave discharges, kainic acid-induced seizures, fast sodium current, hippocampal neurons, neuronal hyperexcitability, epilepsy, neurodegeneration
- MeSH terms
- Action Potentials, Aging, Animals, Axons, Brain, Cell Membrane, Hippocampus, Kainic Acid, Membrane Potentials, Nerve Degeneration, Neurons, Phenotype, Seizures, Sodium Channels, Aspartic Acid Endopeptidases, Mice, Knockout, Mice, Amyloid Precursor Protein Secretases, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
